Prediction of Metastasis-Free Survival in Patients with Localized Prostate Adenocarcinoma Using Delta Radiomics from Pre-Treatment PSMA-PET/CT Scans and Dosiomics
Integrating delta radiomics or dosiomics with pre-treatment imaging and clinical variables improves MFS prediction and supports their role as non-invasive biomarkers for individualized radiotherapy in localized prostate cancer.
Authors
- C. Onal
- Birhan Demirhan (ORCID: https://orcid.org/0000-0002-3551-9000)
- Apurva Singh (ORCID: https://orcid.org/0000-0001-5600-800X)
- Sang-Bo Oh (ORCID: https://orcid.org/0000-0001-7257-0350)
- William Silva Mendes
- L. Ren
- Phuoc Tran
- Ozan Cem Guler
- Aysenur Elmali
Institutions
- University of Maryland, Baltimore (US)
- The University of Texas MD Anderson Cancer Center (US)
- Başkent University (TR)
- Pusan National University Yangsan Hospital (KR)
Publication Details
- Journal
- Cancers
- Published
- 2026-02-19
- DOI
- https://doi.org/10.3390/cancers18040677
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00